COVID-19 Rapid test kit
Allows testing for both IgM and IgG antibodies. This device has a proven good clinical performance.
The COVID-19 Rapid Test is an in vitro diagnostic test. It allows the qualitative determination of COVID-19âs IgM and IgG antibodies in human whole blood, serum, plasma and fingertip blood. The test kit is for in vitro diagnostic use only and can be used in point-of-care testing settings and central laboratories. It is based on immunoassay technology.
Each COVID-19 Rapid test kit box contains 18 boxes. Each box = 40x test devices, 40x pipettes, two bottles of buffer.
The Primer Design Winterplex Kit allows for All-in-one detection for all strains of winter virus in one simple test: Influenza A, Influenza B, RSV and SARS-CoV-2 (Lyolised) CE-IVD
The genesig qPCR detection kits for nCoV-2019 allows specific early detection of the virus with CE-IVD, USFDA, WHO approvals. Two gene lyolized Covid-19 RT-PCR kits are also available for markets which requirethose. The Anti-SARS-CoV-2 Rapid Test Kit is a lateral flow immunoassay intended for the qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human plasma from anticoagulated blood (Heparin/ EDTA/ sodium citrate) or serum.
The viral strain called SARS-CoV-2, previously 2019-nCoV, is known to cause fatalities and spread through human to human transmission causing a widerspread global impact. For the emergence of the new virual strain of Coronavirus, we offer complete laboratory setup and consumbales from sample collection, transportation, to in-lab equipment for Viral RNA Extraction and Viral Detection. With the imporance of COVID-19 environmental monitoring we also offer solutions and methods for monitoring air and surfaces for pathogens, as well as concentration of SARS-CoV-2 for wastewater-based epidemiology.